Cancer BiologybioRxivPreprint
Whole genome sequencing provides evidence of two biologically and clinically distinct entities of asymptomatic monoclonal gammopathies: progressive versus stable myeloma precursor condition
B. Oben, G. Froyen, K. H. Maclachlan…·F. Maura
The paper uses whole genome sequencing to identify two distinct myeloma precursor conditions, progressive and stable, based on genomic features.
DOI 10.1101/2020.11.06.372011